Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1977 Jun;5(6):551–558. doi: 10.1128/jcm.5.6.551-558.1977

Comparison of antibody-dependent cellular cytotoxicity and complement-dependent antibody lysis of herpes simplex virus-infected cells as methods of detecting antiviral antibodies in human sera.

T Subramanian, W E Rawls
PMCID: PMC274654  PMID: 195975

Abstract

An antibody-dependent cellular cytotoxicity (ADCC) assay was used to detect antibodies to the herpes simplex viruses in humans sera. The assay utilized the release of 51Cr from BHK-21 cells infected with the viruses, hamster peritoneal exudate cells as effector cells, and antiviral antibodies in human sera. The technique was found to be far more sensitive than complement-dependent antibody lysis of infected cells and virus neutralization. The ADCC assay was useful in detecting antibodies in sera that had low titers or no antibodies detectable by other methods. In a sample of 100 sera from university students, 40 were positive by complement-dependent lysis whereas 73 were positive by ADCC. Of 400 sera from women with cervical cancer, 17 did not have detectable antibodies by microneutralization or complement-dependent lysis; however, all sera were positive by ADCC, suggesting that all of the women had been infected in the past with one or both types of herpes simplex virus.

Full text

PDF
551

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adelusi B., Osunkoya B. O., Fabiyi A. Antibodies to herpesvirus type 2 in carcinoma of the cervix uteri in Ibadan, Nigeria. Am J Obstet Gynecol. 1975 Dec 1;123(7):758–761. doi: 10.1016/0002-9378(75)90502-5. [DOI] [PubMed] [Google Scholar]
  2. BUDDINGH G. J., SCHRUM D. I., LANIER J. C., GUIDRY D. J. Studies of the natural history of herpes simplex infections. Pediatrics. 1953 Jun;11(6):595–610. [PubMed] [Google Scholar]
  3. Cesario T. C., Poland J. D., Wulff H., Chin T. D., Wenner H. A. Six years experience with herpes simplex virus in a children's home. Am J Epidemiol. 1969 Nov;90(5):416–422. doi: 10.1093/oxfordjournals.aje.a121087. [DOI] [PubMed] [Google Scholar]
  4. Christenson B., Espmark A. Long-term follow-up studies on herpes simplex antibodies in the course of cervical cancer. II. Antibodies to surface antigen of Herpes simplex virus infected cells. Int J Cancer. 1976 Mar 15;17(3):318–325. doi: 10.1002/ijc.2910170307. [DOI] [PubMed] [Google Scholar]
  5. Douglas R. G., Jr, Couch R. B. A prospective study of chronic herpes simplex virus infection and recurrent herpes labialis in humans. J Immunol. 1970 Feb;104(2):289–295. [PubMed] [Google Scholar]
  6. Freedman R. S., Joosting A. C., Ryan J. T., Nkoni S. A study of associated factors, including genital herpes, in Black women with cervical carcinoma in Johannesburg. S Afr Med J. 1974 Aug 24;48(41):1747–1752. [PubMed] [Google Scholar]
  7. Glezen W. P., Fernald G. W., Lohr J. A. Acute respiratory disease of university students with special reference to the etiologic role of Herpesvirus hominis. Am J Epidemiol. 1975 Feb;101(2):111–121. doi: 10.1093/oxfordjournals.aje.a112077. [DOI] [PubMed] [Google Scholar]
  8. JAWETZ E., ALLENDE M. F., COLEMAN V. R. Studies on herpes simplex virus. IV. The level of neutralizing antibodies in human sera. J Immunol. 1952 Jun;68(6):655–661. [PubMed] [Google Scholar]
  9. Johnson R. T., Olson L. C., Buescher E. L. Herpes simplex virus infections of the nervous system. Problems in laboratory diagnosis. Arch Neurol. 1968 Mar;18(3):260–264. doi: 10.1001/archneur.1968.00470330050004. [DOI] [PubMed] [Google Scholar]
  10. Kao C. L., Chen Y. H., Tang M. C., Wen H. K., Hsia S. Association of herpes simplex type 2 virus with cervical cancer of the uterus. Taiwan Yi Xue Hui Za Zhi. 1974 Feb;73(2):122–127. [PubMed] [Google Scholar]
  11. Kawana T., Yoshino K., Kasamatsu T. Estimation of specific antibody to type 2 Herpes simplex virus among patients with carcinoma of the uterine cervix. Gan. 1974 Oct;65(5):439–445. [PubMed] [Google Scholar]
  12. McClung H., Seth P., Rawls W. E. Quantitation of antibodies to Herpes simplex virus types 1 and 2 by complement-dependent antibody lysis of infected cells. Am J Epidemiol. 1976 Aug;104(2):181–191. doi: 10.1093/oxfordjournals.aje.a112288. [DOI] [PubMed] [Google Scholar]
  13. McDonald A. D., Williams M. C., West R., Stewart J. Neutralizing antibodies to herpesvirus types 1 and 2 in Montreal women. Am J Epidemiol. 1974 Aug;100(2):124–129. doi: 10.1093/oxfordjournals.aje.a112014. [DOI] [PubMed] [Google Scholar]
  14. Menczer J., Leventon-Kriss S., Modan M., Oelsner G., Gerichter C. B. Antibodies to Herpes simplex virus in Jewish women with cervical cancer and in healthy Jewish women of Israel. J Natl Cancer Inst. 1975 Jul;55(1):3–6. doi: 10.1093/jnci/55.1.3. [DOI] [PubMed] [Google Scholar]
  15. Muñoz N., de-Thé G., Aristizabal N., Yee C., Rabson A., Pearson G. Antibodies to herpesviruses in patients with cervical cancer and controls. IARC Sci Publ. 1975;(11 Pt 2):45–51. [PubMed] [Google Scholar]
  16. Ory H., Conger B., Richart R., Barron B. Relation of type 2 Herpesvirus antibodies to cervical neoplasia. Barbados, West Indies, 1971. Obstet Gynecol. 1974 Jun;43(6):901–904. [PubMed] [Google Scholar]
  17. Pacsa A. S., Kummerländer L., Pejtsik B., Pali K. Herpesvirus antibodies and antigens in patients with cervical anaplasia and in controls. J Natl Cancer Inst. 1975 Oct;55(4):775–781. doi: 10.1093/jnci/55.4.775. [DOI] [PubMed] [Google Scholar]
  18. Porter D. D., Wimberly I., Benyesh-Melnick M. Prevalence of antibodies to EB virus and other herpesviruses. JAMA. 1969 Jun 2;208(9):1675–1679. [PubMed] [Google Scholar]
  19. Rager-Zisman B., Bloom B. R. Immunological destruction of herpes simplex virus I infected cells. Nature. 1974 Oct 11;251(5475):542–543. doi: 10.1038/251542a0. [DOI] [PubMed] [Google Scholar]
  20. Rawls W. E., Adam E., Melnick J. L. An analysis of seroepidemiological studies of herpesvirus type 2 and carcinoma of the cervix. Cancer Res. 1973 Jun;33(6):1477–1482. [PubMed] [Google Scholar]
  21. Rawls W. E., Garfield C. H., Seth P., Adam E. Serological and epidemiological considerations of the role of herpes simplex virus type 2 in cervical cancer. Cancer Res. 1976 Feb;36(2 Pt 2):829–835. [PubMed] [Google Scholar]
  22. Rawls W. E., Iwamoto K., Adam E., Melnick J. L. Measurement of antibodies to herpesvirus types 1 and 2 in human sera. J Immunol. 1970 Mar;104(3):599–606. [PubMed] [Google Scholar]
  23. SCOTT T. F. M. Epidemiology of herpetic infections. Am J Ophthalmol. 1957 Apr;43(4 Pt 2):134–147. doi: 10.1016/0002-9394(57)91496-4. [DOI] [PubMed] [Google Scholar]
  24. Seth P., Rawls W. E., Duff R., Rapp F., Adam E., Melnick J. L. Antigenic differences between isolates of herpesvirus type 2. Intervirology. 1974;3(1-2):1–14. doi: 10.1159/000149738. [DOI] [PubMed] [Google Scholar]
  25. Shore S. L., Black C. M., Melewicz F. M., Wood P. A., Nahmias A. J. Antibody-dependent cell-mediated cytotoxicity to target cells infected with type 1 and type 2 herpes simplex virus. J Immunol. 1976 Jan;116(1):194–201. [PubMed] [Google Scholar]
  26. Smith I. W., Peutherer J. F., MacCallum F. O. The incidence of Herpesvirus hominis antibody in the population. J Hyg (Lond) 1967 Sep;65(3):395–408. doi: 10.1017/s0022172400045915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Thomas D. B., Anderson R. I. An epidemiologic and serologic comparison of uterine carcinoma in situ and squamous dysplasia. Am J Epidemiol. 1974 Aug;100(2):113–123. doi: 10.1093/oxfordjournals.aje.a112013. [DOI] [PubMed] [Google Scholar]
  28. Wentworth B. B., Alexander E. R. Seroepidemiology of infectious due to members of the herpesvirus group. Am J Epidemiol. 1971 Nov;94(5):496–507. doi: 10.1093/oxfordjournals.aje.a121347. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES